SCHEMBL5217248

SCHEMBL5217248

CCNc1cccc(-c2c(C)noc2C)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 14/20 0.58
BRD2 P25440 10/20 0.58
CREBBP Q92793 3/20 0.58
HDAC1 Q13547 1/20 0.55
BRD3 Q15059 6/20 0.49
FFAR1 O14842 1/20 0.47
MAP4K4 O95819 1/20 0.47
USP2 O75604 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
NPC1 O15118 1/20 0.45
POLB P06746 1/20 0.45
CASP3 P42574 1/20 0.45
RAB9A P51151 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
ERN1 O75460 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12095520 0.82 BRD4 (0.57) BRD4BRD2CREBBPHDAC1BRD3
SCHEMBL12881340 0.78 BRD4 (0.59) BRD4BRD2CREBBPBRD3FFAR1
SCHEMBL12487 0.76 NPC1 (0.69) BRD4BRD2CREBBPBRD3MAP4K4
SCHEMBL1904650 0.73 DHODH (0.66) BRD4BRD2CREBBPHDAC1CYP3A4
SCHEMBL16404612 0.73 BRD4 (0.62) BRD4BRD2CREBBPBRD3MAP4K4
SCHEMBL16246450 0.73 BRD4 (0.62) BRD4BRD2CREBBPBRD3MAP4K4
SCHEMBL980536 0.73 MAP4K4 (0.76) BRD4BRD2CREBBPBRD3MAP4K4
SCHEMBL9657290 0.73 BRD4 (0.62) BRD4BRD2CREBBPHDAC1BRD3
SCHEMBL16675743 0.73 BRD4 (0.58) BRD4BRD2CREBBPHDAC1BRD3
SCHEMBL20946455 0.73 BRD4 (0.57) BRD4BRD2CREBBPBRD3FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581516-A4 3-HETEROCYCLIC BENZYLAMIDE DERIVATIVES AS POTASSIUM CHANNEL OPENERS BRISTOL MYERS SQUIBB CO (US) 2007-10-17 EP disclosed
EP-1581516-A2 3-HETEROCYCLIC BENZYLAMIDE DERIVATIVES AS POTASSIUM CHANNEL OPENERS Bristol-Myers Squibb Company (US) 2005-10-05 EP disclosed
WO-2004047744-A2 3-HETEROCYCLIC BENZYLAMIDE DERIVATIVES AS POTASSIUM CHANNEL OPENERS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-06-10 WO disclosed